These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9229959)
21. Liposomal antisense oligonucleotides for cancer therapy. Siwak DR; Tari AM; Lopez-Berestein G Methods Enzymol; 2004; 387():241-53. PubMed ID: 15172168 [No Abstract] [Full Text] [Related]
22. Antisense therapy for cancer. Gleave ME; Monia BP Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854 [TBL] [Abstract][Full Text] [Related]
23. Applications of antisense oligonucleotides in oncology. Pierga JY; Magdelenat H Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172 [TBL] [Abstract][Full Text] [Related]
24. Ribosomal protein P2: a potential molecular target for antisense therapy of human malignancies. Gardner-Thorpe J; Ito H; Ashley SW; Whang EE Anticancer Res; 2003; 23(6C):4549-60. PubMed ID: 14981896 [TBL] [Abstract][Full Text] [Related]
27. Molecular approaches to cancer therapy. Israel MA Adv Cancer Res; 1993; 61():57-85. PubMed ID: 8346720 [No Abstract] [Full Text] [Related]
28. Antisense tumor therapy (a dream under construction). Kopper L; Kovalszky I In Vivo; 1994; 8(5):781-6. PubMed ID: 7727725 [TBL] [Abstract][Full Text] [Related]
29. European School of Oncology Task Force Papers: gene therapy--a future in cancer management? Antisense therapy for malignant disease. O'Brien SG; Kirkland MA; Goldman JM Eur J Cancer; 1994; 30A(8):1160-4. PubMed ID: 7654449 [No Abstract] [Full Text] [Related]
30. 10 years and counting: the hype and hope of cancer biotechnology. Morris K Lancet Oncol; 2002 Oct; 3(10):582. PubMed ID: 12372706 [No Abstract] [Full Text] [Related]
31. Antisense technology and prospects for therapy of viral infections and cancer. Wagner RW; Flanagan WM Mol Med Today; 1997 Jan; 3(1):31-8. PubMed ID: 9021740 [TBL] [Abstract][Full Text] [Related]
32. Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver? Kortylewski M; Nechaev S Ther Deliv; 2014 Mar; 5(3):239-42. PubMed ID: 24592948 [No Abstract] [Full Text] [Related]
33. The therapeutic potential of antisense oligonucleotides. Sharma HW; Narayanan R Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067 [TBL] [Abstract][Full Text] [Related]
38. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology]. Kausch I; Böhle A Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082 [TBL] [Abstract][Full Text] [Related]
39. Advancements of antisense oligonucleotides in treatment of breast cancer. Yang SP; Song ST; Song HF Acta Pharmacol Sin; 2003 Apr; 24(4):289-95. PubMed ID: 12676065 [TBL] [Abstract][Full Text] [Related]
40. RNAi: a novel antisense technology and its therapeutic potential. Dallas A; Vlassov AV Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]